Our team is frequently featured in national journals and news networks —check out the articles below to learn more: Duke-developed immunotherapy for brain tumors heads to clinical trialSep 20, 2026DUKE HEALTH Duke Health News Lab In The news Evaxion expands and refocuses R&D pipeline with EVX-05, an AI-designed off-the-shelf brain cancer vaccine programAug 20, 2026Lab In The news Immunotherapy in cancer research: recent advancements (2026)Jul 2, 2026Lab In The news Richard Scolyer, Cancer Expert Who ‘Became His Own Subject,’ Dies at 59Jun 2, 2026Lab In The news Neoadjuvant Immunotherapy’s Potential as Glioblastoma Treatment: What’s New?Apr 21, 2026Lab In The news Is this rare cancer treatment worth the cost? | A Current AffairMar 20, 2026Lab In The news ‘Incredibly excited’: Richard Scolyer hails new US trial for brain cancerFeb 14, 2026Lab In The news New compound shrinks brain tumors in mice, sparking hope for a glioblastoma pillJan 30, 2026Lab In The news Adaptin Bio Advances Novel Brain Cancer Treatment Candidate Towards Phase 1 Glioblastoma Clinical TrialJan 30, 2026Lab In The news Uncategorized Neurons Can Transfer Mitochondria to Cancer CellsJul 24, 2025Lab In The news Michael Bolton Brain Cancer: What Is Glioblastoma, What Are the Symptoms and Can You Prevent It?May 8, 2025Lab In The news Clinical Trials Are Moving Out of the Lab and Into People’s HomesMay 8, 2025Uncategorized Lab In The news New study highlights telehealth struggles in cancer careMay 8, 2025Lab In The news Injection Immunotherapies Get FDA ApprovalMay 8, 2025Lab In The news Integrated Proteogenomic Characterization of Glioblastoma Evolution: Overcoming Barriers to Develop Personalized Treatment StrategiesMay 8, 2025Lab In The news Uncategorized Signal Alert: Startup Seeks Community Funders for AAV Immuno-Gene TherapyMay 8, 2025Lab In The news Michael Bolton diagnosed with brain cancer glioblastoma. What is that?May 8, 2025Lab In The news The Khasraw Lab in Duke Health News Duke-developed immunotherapy for brain tumors heads to clinical trialSep 20, 2026DUKE HEALTH Duke Health News Lab In The news Mustafa Khasraw to Lead U.S. Arm of International Glioblastoma TrialMay 12, 2025DUKE HEALTH Uncategorized Analysis Details Lasting Effects of the Covid-19 Pandemic on Cancer CareMay 12, 2025DUKE HEALTH Evaluation of fluoxetine (Prozac) and Cytotoxic Lysosomal Stress in Glioma (FLIrT)May 12, 2025DUKE HEALTH Q&A: The MOAB Trial – Now Enrolling. Click to learn more!May 12, 2025DUKE HEALTH Uncategorized PuMP: Oncolytic HSV1 MVR-C5252 in Patients with rHGG (Recurrent Glioma)May 12, 2025DUKE HEALTH Q&A: PuMP Trial for Recurrent GlioblastomaMay 12, 2025DUKE HEALTH
